Frequently Asked Questions
The U.S. Telestroke Market size will be worth USD 4,672.23 million by 2031 during the forecast period.
The U.S. Telestroke Market growth rate is 19.1% during the forecast period.
The Time Sensitive Interventions and Integration with Healthcare Systems are the growth drivers of the U.S. Telestroke Market.
The component, facilities service, care settings, deployment type, stroke type, application, end user and distribution channel are the factors on which the U.S. Telestroke Market research is based.
The major companies in the U.S. Telestroke Market are Abbott (U.S.), GE Healthcare (a subsidiary of General Electric) (U.S.), VeeMed (U.S.), swyMe (U.S.), TeleSpecialists (U.S.), American Well (U.S.), InTouch Technologies, Inc. (a subsidiary of Teladoc Health, Inc.) (U.S.), iSchemaView, Inc. (U.S.), The General Hospital Corporation (U.S.), Brigham and Women's Hospital (U.S.) , Providence Health & Services (U.S.), Medical University of South Carolina (U.S.), Lakewood Health System (U.S.), Nebraska Medicine (U.S.), CentraCare (U.S.), Mayo Foundation for Medical Education and Research (MFMER) (U.S.) , Rush Medical University Center (U.S.), Penn Medicine (U.S.), UCLA Health (U.S.), Medtronic (Ireland).
